Intervention not reported
Language – expression (direct or independent assessment) PLS‐IV, MSEL1 · children aged 1 year to 6 years 11 months with diagnosis of ASD
1 finding from 1 review
Intervention not reported
Language – Comprehension (direct or independent assessment) PLS, MSEL1 · children aged 1 year to 6 years 11 months with diagnosis of ASD
1 finding from 1 review
Intervention not reported
Parent‐child interaction (parent synchrony) · children aged 1 year to 6 years 11 months with diagnosis of ASD
1 finding from 1 review
Intervention not reported
Parents'level of stress PSI, SAC1 · children aged 1 year to 6 years 11 months with diagnosis of ASD
1 finding from 1 review
Brush biopsy (oral cytology) vs No screening
Outcome not reported · Planned population: general population or high-risk / opportunistic screening groups (no eligible study)
The review found no eligible studies for this question.
1 finding from 1 review
Fluorescence imaging / light-based techniques vs No screening
Outcome not reported · Planned population: general population or high-risk / opportunistic screening groups (no eligible study)
The review found no eligible studies for this question.
1 finding from 1 review
Survival (proportion alive after diagnosis) · Apparently healthy adults aged 35 years or older (general population), living in 13 clusters in rural areas of Trivandrum city, Kerala,…
1 finding from 1 review
Hospital admissions · patients with acute asthma
ICS may leads to lower hospital admission compared with placebo (low certainty).
1 finding from 1 review
FEV1 (L) · patients with acute asthma
ICS showed no clear difference in FEV1 at 1 hour compared with placebo (low certainty).
1 finding from 1 review
FEV1 · patients with acute asthma
ICS showed no clear difference in FEV1 at 3 to 4 hours compared with placebo (moderate certainty).
1 finding from 1 review
Nausea and vomiting · patients with acute asthma
ICS showed no clear difference in adverse effects ‐ nausea/vomiting compared with placebo (low certainty).
1 finding from 1 review
Hospital admissions · patients with acute asthma
ICS showed no clear difference in hospital admission compared with systemic corticosteroids (low certainty).
1 finding from 1 review
Progression to psychosis ‐ by 12 months · people with psychosis
PHASE SPECIFIC TREATMENT (RISPERIDONE + CBT) + SPECIALISED TEAM probably leads to lower progression to psychosis ‐ by 6 months compared with SPECIALISED TEAM (moderate certainty).
2 findings from 1 review
Compliance with treatment ‐ treatment stopped in spite of need ‐ by one year · people with psychosis
SPECIALISED TEAM probably leads to lower compliance with treatment ‐ treatment stopped in spite of need ‐ by… compared with STANDARD CARE (moderate certainty).
1 finding from 1 review
Compliance with treatment ‐ treatment stopped in spite of need ‐ by two years · people with psychosis
SPECIALISED TEAM showed no clear difference in compliance with treatment ‐ treatment stopped in spite of need ‐ by… compared with STANDARD CARE (moderate certainty).
1 finding from 1 review
Service use: 1. Average number of days in hospital per month ‐ by about 24 months · people with psychosis
1 finding from 1 review
Service use: 2. Not hospitalised ‐ by five years · people with psychosis
SPECIALISED TEAM showed no clear difference in service use: 2. Not hospitalised ‐ by five years compared with STANDARD CARE (moderate certainty).
1 finding from 1 review
Social outcomes: 1. Not living independently ‐ by 5 years · people with psychosis
SPECIALISED TEAM probably leads to lower social outcomes: 1. Not living independently ‐ by 5 years compared with STANDARD CARE (moderate certainty).
1 finding from 1 review
Social outcomes: 2. Not working or in education ‐ by 5 years · people with psychosis
SPECIALISED TEAM showed no clear difference in social outcomes: 2. Not working or in education ‐ by 5 years compared with STANDARD CARE (moderate certainty).
1 finding from 1 review
Intervention not reported
All‐cause mortality at 2 days ‐ immediate treatment · patients with acute myocardial infarction1
The intervention leads to lower all‐cause mortality at 2 days ‐ immediate treatment (high certainty).
1 finding from 1 review